Skip to main content

Lilly Endowment Inc's Form 4 filing

Eli Lilly & Co (LLY) · filed Jun 23, 2023

Accession no.
0001209191-23-039261
Filed
Jun 23, 2023
Trade date
Jun 22, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 8 non-derivative transactions. Open-market sales total $49.2M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lilly Endowment IncCIK 000031601110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 22, 2023Common StockSSaleDisposed−4,801$455.44F1−$2,186,567.44101,351,031Direct
Jun 22, 2023Common StockSSaleDisposed−5,163$456.60F2−$2,357,425.8101,345,868Direct
Jun 22, 2023Common StockSSaleDisposed−20,132$457.65F3−$9,213,409.8101,325,736Direct
Jun 22, 2023Common StockSSaleDisposed−6,455$458.51F4−$2,959,682.05101,319,281Direct
Jun 22, 2023Common StockSSaleDisposed−31,803$459.72F5−$14,620,475.16101,287,478Direct
Jun 22, 2023Common StockSSaleDisposed−26,924$460.44F6−$12,396,886.56101,260,554Direct
Jun 22, 2023Common StockSSaleDisposed−11,444$461.43F7−$5,280,604.92101,249,110Direct
Jun 22, 2023Common StockSSaleDisposed−300$462.11F8−$138,633101,248,810Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $455.00 to $455.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), and (8) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $456.00 to $456.99, inclusive.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $457.015 to $457.98, inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $458.02 to $459.01, inclusive.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $459.02 to $460.015, inclusive.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $460.02 to $461.015, inclusive.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $461.02 to $462.015, inclusive.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $462.04 to $462.23, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)